Sunshine Biopharma
SBFMSunshine Biopharma Inc. (SBFM) is a Canadian pharmaceutical company engaged in the research, development, and commercialization of novel therapeutics. The company's primary business focus is on creating new drugs for the treatment of cancer and other life-threatening diseases. It is publicly traded on the NASDAQ Capital Market under the ticker symbol SBFM. The company's pipeline includes several drug candidates targeting various forms of cancer. Its lead compound is a small molecule designed to inhibit the translation of specific cancer-related proteins, including the multi-drug resistance protein P-glycoprotein. Sunshine Biopharma is also developing an mRNA-based anticancer vaccine technology in collaboration with the University of Georgia. Beyond oncology, the company has commercialized a line of generic prescription and non-prescription medicines in Canada through its subsidiary, Sunshine Biopharma Canada Inc. Sunshine Biopharma's operations encompass both proprietary drug development and the distribution of established pharmaceutical products. This structure supports its research initiatives aimed at advancing its clinical-stage assets. The company's research activities are conducted primarily from its facilities in Montreal, Quebec.
SBFM · Stock Price
Historical price data
About
Sunshine Biopharma Inc. (SBFM) is a Canadian pharmaceutical company engaged in the research, development, and commercialization of novel therapeutics. The company's primary business focus is on creating new drugs for the treatment of cancer and other life-threatening diseases. It is publicly traded on the NASDAQ Capital Market under the ticker symbol SBFM. The company's pipeline includes several drug candidates targeting various forms of cancer. Its lead compound is a small molecule designed to inhibit the translation of specific cancer-related proteins, including the multi-drug resistance protein P-glycoprotein. Sunshine Biopharma is also developing an mRNA-based anticancer vaccine technology in collaboration with the University of Georgia. Beyond oncology, the company has commercialized a line of generic prescription and non-prescription medicines in Canada through its subsidiary, Sunshine Biopharma Canada Inc. Sunshine Biopharma's operations encompass both proprietary drug development and the distribution of established pharmaceutical products. This structure supports its research initiatives aimed at advancing its clinical-stage assets. The company's research activities are conducted primarily from its facilities in Montreal, Quebec.